Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela George

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Current Opinion in Oncology|July 24, 2018
Inherited gynaecological cancersAngela George
British Journal of Cancer|December 17, 2015
UK BRCA mutation testing in patients with ovarian cancerAngela George
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|February 5, 2009
Positive attitude change toward psychiatry in pharmacy students following an active learning psychopharmacology courseHaim Einat, Angela George
Genes, Chromosomes & Cancer|November 22, 2020
Tumor-only sequencing for oncology management: Germline-focused analysis and implicationsAngela George, Clare Turnbull
Genes, Chromosomes & Cancer|December 31, 2020
PARP inhibitors in ovarian cancer: An overview of the practice-changing trialsTiffany Foo, Angela George, Susana Banerjee
Expert Review of Anticancer Therapy|August 11, 2018
Olaparib for the treatment of relapsed ovarian cancer with a BRCA1/2 mutationJames Stewart, Angela George, Susana Banerjee
Oncotarget|June 15, 2017
Olaparib and somatic BRCA mutationsAngela George, Susana Banerjee, Stan Kaye
Best Practice & Research. Clinical Obstetrics & Gynaecology|March 4, 2020
Genetic testing for epithelial ovarian cancerNoa Amin, Narda Chaabouni, Angela George
Nature Reviews. Clinical Oncology|December 14, 2016
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancerAngela George, Stan Kaye, Susana Banerjee
Tumori|October 8, 2016
The current status of PARP inhibitors in ovarian cancerJennifer McLachlan, Angela George, Susana Banerjee
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Opinion in Oncology|July 24, 2018
Inherited gynaecological cancersAngela George
British Journal of Cancer|December 17, 2015
UK BRCA mutation testing in patients with ovarian cancerAngela George
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|February 5, 2009
Positive attitude change toward psychiatry in pharmacy students following an active learning psychopharmacology courseHaim Einat, Angela George
Genes, Chromosomes & Cancer|November 22, 2020
Tumor-only sequencing for oncology management: Germline-focused analysis and implicationsAngela George, Clare Turnbull
Genes, Chromosomes & Cancer|December 31, 2020
PARP inhibitors in ovarian cancer: An overview of the practice-changing trialsTiffany Foo, Angela George, Susana Banerjee
Expert Review of Anticancer Therapy|August 11, 2018
Olaparib for the treatment of relapsed ovarian cancer with a BRCA1/2 mutationJames Stewart, Angela George, Susana Banerjee
Oncotarget|June 15, 2017
Olaparib and somatic BRCA mutationsAngela George, Susana Banerjee, Stan Kaye
Best Practice & Research. Clinical Obstetrics & Gynaecology|March 4, 2020
Genetic testing for epithelial ovarian cancerNoa Amin, Narda Chaabouni, Angela George
Nature Reviews. Clinical Oncology|December 14, 2016
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancerAngela George, Stan Kaye, Susana Banerjee
Tumori|October 8, 2016
The current status of PARP inhibitors in ovarian cancerJennifer McLachlan, Angela George, Susana Banerjee
Pageof 5